| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
15,452 |
13,423 |
$636K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,434 |
4,539 |
$309K |
| Q3014 |
Telehealth originating site facility fee |
11,016 |
9,264 |
$164K |
| 99233 |
Prolong inpt eval add15 m |
2,797 |
594 |
$156K |
| 99205 |
Prolong outpt/office vis |
1,411 |
1,191 |
$146K |
| 99223 |
Prolong inpt eval add15 m |
686 |
511 |
$88K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
2,613 |
2,078 |
$72K |
| 99335 |
|
2,473 |
1,319 |
$71K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
723 |
547 |
$49K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
949 |
516 |
$40K |
| 90837 |
Psychotherapy, 53 minutes with patient |
470 |
227 |
$13K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
456 |
424 |
$9K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
641 |
575 |
$7K |
| 99495 |
|
69 |
63 |
$6K |
| 99327 |
|
54 |
46 |
$3K |
| 99348 |
|
66 |
28 |
$2K |
| 99415 |
Prolong outpt/office vis |
350 |
308 |
$2K |
| 90876 |
|
30 |
21 |
$852.30 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
59 |
51 |
$713.16 |
| G0181 |
Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allowed practitioner development and/or revision of care plans |
28 |
26 |
$418.00 |
| 99358 |
Prolong nursin fac eval 15m |
60 |
49 |
$333.70 |
| 90901 |
|
96 |
51 |
$316.54 |
| 4004F |
|
419 |
108 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,634 |
528 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
252 |
69 |
$0.00 |
| 99354 |
|
17 |
15 |
$0.00 |
| 1123F |
|
1,489 |
503 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
209 |
51 |
$0.00 |